Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Henna glycerogelatin vaginal suppository for cervicitis
IRCT20260726070364N1Phase 3Recruiting
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Sep 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of henna in cervicitis (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Change in cervicitis-related clinical signs and symptoms, Cervical lesion size and 7 more. Started Sep 2026; status: recruiting.
02
Drugs
henna
03
Conditions
cervicitis
Beyond the preview
Go deeper on IRCT20260726070364N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260726070364N1.